tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Milestone Pharmaceuticals (MIST)
NASDAQ:MIST
US Market
MIST
Milestone Pharmaceuticals
Overview
Analyst Forecasts
AI Stock Analysis
Popular
Dividends
Earnings
Ownership
Financials
Statistics
New
Technical Analysis
Historical Prices
New
Chart
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports

Milestone Pharmaceuticals (MIST) Stock News & Sentiment

Compare
575 Followers
Milestone Pharmaceuticals: Buy Rating Affirmed Despite CARDAMYST Approval Delay, Strong Market Potential and Robust Financial Position
Premium
Ratings
Milestone Pharmaceuticals: Buy Rating Affirmed Despite CARDAMYST Approval Delay, Strong Market Potential and Robust Financial Position
16d ago
MIST
Milestone Pharmaceuticals: Buy Rating Backed by Promising FDA Approval and Market Expansion Prospects
Premium
Ratings
Milestone Pharmaceuticals: Buy Rating Backed by Promising FDA Approval and Market Expansion Prospects
27d ago
MIST
Optimistic Buy Rating for Milestone Pharmaceuticals Driven by Strategic Plans and Financial Strength
Premium
Ratings
Optimistic Buy Rating for Milestone Pharmaceuticals Driven by Strategic Plans and Financial Strength
1M ago
MIST
Milestone Pharmaceuticals’ SEC Exemptions: Balancing Reduced Disclosure with Investor Confidence Risks
Premium
Company Announcements
Milestone Pharmaceuticals’ SEC Exemptions: Balancing Reduced Disclosure with Investor Confidence Risks
1M ago
MIST
Milestone Pharmaceuticals Eyes FDA Approval for CARDAMYST
Premium
Company Announcements
Milestone Pharmaceuticals Eyes FDA Approval for CARDAMYST
1M ago
MIST
Milestone Pharmaceuticals Awaits FDA Decision on CARDAMYST, Prepares for Mid-2025 Launch
Premium
Company Announcements
Milestone Pharmaceuticals Awaits FDA Decision on CARDAMYST, Prepares for Mid-2025 Launch
1M ago
MIST
Milestone Pharmaceuticals Prepares for CARDAMYST Launch
Premium
Company Announcements
Milestone Pharmaceuticals Prepares for CARDAMYST Launch
2M ago
8K
MIST
More MIST News >

MIST News on the Web

MIST Stock Falls 66% Following Complete Response Letter for Cardamyst
Zacks
Neutral
Milestone Pharmaceuticals (MIST) Receives FDA Response on Etripamil NDA
GuruFocus News
Neutral
Milestone CRL affirms integrity of clinical data, says H.C. Wainwright
The Fly
Neutral
FDA Declines Milestone Pharmaceuticals' (MIST) Heart Drug Approval
GuruFocus News
Neutral
Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635
Yahoo Finance
Neutral
TD Cowen Keeps Their Buy Rating on Milestone Pharmaceuticals (MIST)
TipRanks News
Neutral
Milestone Pharmaceuticals Gets Notice of Allowance for US Patent on Etripamil Nasal Spray
Yahoo Finance
Neutral
Milestone® Pharmaceuticals Notice of Allowance on New U.S. Patent for Etripamil
Yahoo Finance
Neutral

News Score - Last 7 Days

Neutral
MIST
Sector Average
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
This Week50%
Sector Average61%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is MIST’s Media Buzz Sentiment?
Currently, no data Available
What is MIST’s weekly average amount of articles?
Currently, no data Available
What is MIST’s News Sentiment?
50% of articles about MIST were positive this week, compared to its sector average of 61%.
    Healthcare Stocks that are Trending in the News
    THTXTheratechnologies
    NKTRNektar Therapeutics
    SENSSenseonics Holdings
    MBOTMicrobot Medical
    RYTMRhythm Pharmaceuticals
    Showing the stocks with the most bullish news sentiment over the past week

    Become an Expert with TipRanks Premium

    What am I Missing?
    Make informed decisions based on Top Analysts' activity
    Know what industry insiders are buying
    Get actionable alerts from top Wall Street Analysts
    Find out before anyone else which stock is going to shoot up
    Get powerful stock screeners & detailed portfolio analysis
    Subscribe NowSee Plans & Pricing